Drug Approval | April 11, 2023
Zydus receives final approval from the USFDA for Azithromycin Tablets
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
According to IQVIA sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 mg and 10 mg market achieved annual sales of approximately US $26.9 million
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
The Ministry of Ayush endeavour is to get entry level NABH certification for 12,500 Ayush Wellness Centers by the end of 2023
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
Subscribe To Our Newsletter & Stay Updated
